InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,048.42
(
-0.46%
)
US TECH 100
17,162.40
(
1.09%
)
Dow Jones
38,085.80
(
-0.98%
)
Brent Oil
88.09
(
-0.07%
)
Bitcoin
64,407.87
(
-0.12%
)
Post# of 111452
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

$Pistol Pete$

Send PM Follow Ignore
Followers 2543
Posts 250731
Boards Moderated 34
Alias Born 05/06/2014

$Pistol Pete$

Re: None

Tuesday, 04/11/2017 12:14:32 AM

Tuesday, April 11, 2017 12:14:32 AM

Post# of 111452
$PMCB PharmaCyte Biotech PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) to protect its therapy to treat cancerous tumors, including the therapy that will be used in its upcoming clinical trial in locally advanced pancreas cancer (LAPC). 3 reasons to vote for us:

1. a new kind of Chemo without side effects

2. a new treatment for Pancreatic Cancer

3. a chance to give a person that is dying a better quality of life and a chance to live - See more at: http://convention.bio.org/buzzofbio/voting.aspx#verifythankyou

http://convention.bio.org/buzzofbio/voting.aspx#

investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up